CD14 and hepatocellular carcinoma: Finding that PCV1 is able to infect CD4+, CD8+, CD14+, CD19+ and CD56+ human cells [21], and the observation of productive PCV1 infection in a subclone of a human hepatocellular carcinoma cell line [22] suggests potential risks for humans.